Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN102965403A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102965403A reveals a novel recombinant ketoreductase method for statin side chains, offering superior purity and simplified downstream processing for pharmaceutical manufacturers.